Even after its sharp pullback, Space Exploration Technologies' ( SPCX +0.13%) market cap still hovers around $2 trillion.

Eyepoint Pharmaceuticals (NASDAQ:EYPT) executives said the company remains on track to report top-line data from its Phase 3 wet age-related macular degeneration program for DURAVYU, also known as EYP ...

Many of the FDA’s decisions this quarter involve applications that have previously been delayed, declined or outright ...

Eylea HD: FDA Allows Up to 5-Month Dosing With Higher-Strength Formulation for Vision-Threatening Eye Conditions April 3, 2026 — The FDA has approved Eylea HD (aflibercept), a higher-strength ...

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...